Qubit drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (12)
Papers in which this entity is mentioned.
- LINE-1 retrotransposons mediate cis-acting transcriptional control in human pluripotent stem cells and regulate early brain development. (2025)
- Extrachromosomal DNA-Driven Oncogene Spatial Heterogeneity and Evolution in Glioblastoma. (2025)
- Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing. (2023)
- Joint single-cell measurements of nuclear proteins and RNA in vivo. (2021)
- Simultaneous single cell measurements of intranuclear proteins and gene expression (2021)
- Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. (2020)
- Nanopore sequencing and the Shasta toolkit enable efficient de novo assembly of eleven human genomes. (2020)
- Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. (2019)
- CUT&RUNTools: a flexible pipeline for CUT&RUN processing and footprint analysis. (2019)
- Nanopore sequencing and assembly of a human genome with ultra-long reads. (2018)
- Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain. (2017)
- EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma. (2014)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| qubit | drug | 18 | 21 |